Skip to main content
Fig. 1 | Trials

Fig. 1

From: Kangyi Qiangshen Gong exercise prescription for pulmonary function and quality of life in patients recovered from COVID-19: a study protocol for a randomized controlled trial

Fig. 1

Flow chart of the trial. The present study is a randomized controlled trial. Sixty patients will be included and randomized equally to two groups, a BT group and a KQG group. For 30 patients in each group, this trial will include a 12-week treatment period. During the treatment, patients in the BT group will receive breathing techniques intervention, while the KQG group will receive KQG intervention. Both the outcome assessments will be performed at 3 time points, namely the baseline, the end of the treatments at 12 weeks, and 12 weeks of follow-up subsequently

Back to article page

Trials

ISSN: 1745-6215